ROYAL BANK OF CANADA - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 107 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$21,000
+90.9%
10,670
+318.8%
0.00%
Q1 2024$11,000
-86.4%
2,548
-92.7%
0.00%
Q4 2023$81,000
+326.3%
34,863
+133.5%
0.00%
Q3 2023$19,000
-54.8%
14,930
+15.9%
0.00%
Q2 2023$42,000
+100.0%
12,881
+146.6%
0.00%
Q1 2023$21,000
-72.4%
5,224
-60.3%
0.00%
Q4 2022$76,000
+322.2%
13,165
+372.0%
0.00%
Q3 2022$18,000
+800.0%
2,789
+464.6%
0.00%
Q2 2022$2,000
-88.9%
494
-88.8%
0.00%
Q1 2022$18,000
-80.9%
4,397
-70.9%
0.00%
Q4 2021$94,000
+42.4%
15,098
+117.5%
0.00%
Q3 2021$66,000
+3.1%
6,941
+47.2%
0.00%
Q2 2021$64,000
-1.5%
4,715
+18.1%
0.00%
Q1 2021$65,000
+490.9%
3,993
+848.5%
0.00%
Q4 2020$11,000
+450.0%
421
+347.9%
0.00%
Q3 2020$2,000
-33.3%
94
-16.1%
0.00%
Q2 2020$3,000
+200.0%
112
-26.3%
0.00%
Q1 2020$1,000
-94.7%
152
-95.4%
0.00%
Q4 2019$19,000
+1800.0%
3,282
+435.4%
0.00%
Q3 2019$1,000
-83.3%
613
-61.0%
0.00%
Q2 2019$6,000
+200.0%
1,572
+546.9%
0.00%
Q3 2018$2,000
-33.3%
243
+62.0%
0.00%
Q2 2018$3,000
+200.0%
150
+240.9%
0.00%
Q4 2017$1,000
-83.3%
44
-87.6%
0.00%
Q3 2017$6,0003540.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$28,503,4842.94%
Logos Global Management LP 2,800,000$9,212,0001.25%
SILVERARC CAPITAL MANAGEMENT, LLC 1,100,000$3,619,0001.12%
5AM Venture Management, LLC 1,305,000$4,293,4501.07%
SILVERARC CAPITAL MANAGEMENT, LLC 1,000,000$3,290,0001.02%
Decheng Capital Management III (Cayman), LLC 904,268$2,975,0420.93%
Sarissa Capital Management LP 2,632,900$8,662,2410.86%
DAFNA Capital Management LLC 810,845$2,667,6800.73%
Tri Locum Partners LP 428,307$1,409,1300.52%
Avidity Partners Management LP 3,790,000$12,469,1000.44%
View complete list of MERSANA THERAPEUTICS INC shareholders